“…Since extracellular acidification also increases the activity of P-gp, in this way inducing MDR in different cancer cells and tissues [ 125 , 128 , 132 ], it becomes logical to associate PPI with PTI, not only to improve the effect of chemotherapy in metastatic BC, but also to overcome MDR. The clinical use of such a combination is considered a fundamental therapeutic measure in any integrated clinical protocol in the treatment of BC [ 4 , 10 , 30 , 31 , 64 , 67 , 68 , 71 , 72 , 73 , 78 , 101 , 122 , 124 , 139 , 140 , 165 , 167 , 174 , 175 , 180 , 188 , 189 , 190 , 195 , 196 , 197 , 202 , 208 , 233 , 307 , 308 , 309 , 310 , 311 ]. The integral pH-related approach to MDR has shown that the therapeutic failure in inducing the acidification of the cytoplasm and/or reverse CPR is the main factor underlying MDR.…”